Winning Points Advisors, LLC
- SEC CIK
- 0001793399
- Latest filing
- Aug 17, 2026
IBRX holding history
ImmunityBio, Inc. in every 13F filed by Winning Points Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IBRX overviewAll 13F holders of IBRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 726,258
- Value
- $2.29M
- % of portfolio
- 3.0%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 726,258 | $2.29M | 3.0% | +2,685+0.4% | Added | Holders |
| Q1 2026 | 723,573 | $5.32M | 5.3% | +1,200+0.2% | Added | Holders |
| Q4 2025 | 722,373 | $509.0K | 0.6% | – | No prior filing | Holders |
| Q4 2024 | – | – | – | – | Not filed | Holders |
| Q3 2024 | 89,396 | $143.0K | 0.3% | – | No prior filing | Holders |
| Q2 2024 | – | – | – | – | Not filed | Holders |
| Q1 2024 | 92,786 | $465.8K | 0.7% | 00.0% | Unchanged | Holders |
| Q4 2023 | 92,786 | $465.8K | 0.7% | +3,390+3.8% | Added | Holders |
| Q3 2023 | 89,396 | $143.0K | 0.3% | −3,390−3.7% | Reduced | Holders |
| Q2 2023 | 92,786 | $465.8K | 0.7% | −158,400−63.1% | Reduced | Holders |
| Q1 2023 | 251,186 | $461.0K | 0.6% | +8,600+3.5% | Added | Holders |
| Q4 2022 | 242,586 | $1.23M | 1.6% | −8,970−3.6% | Reduced | Holders |
| Q3 2022 | 251,556 | $1.39M | 1.7% | +14,600+6.2% | Added | Holders |
| Q2 2022 | 236,956 | $879.0K | 1.0% | +176,830+294.1% | Added | Holders |
| Q1 2022 | 60,126 | $339.0K | 0.3% | +60,126 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −43,958−100.0% | Sold out | Holders |
| Q3 2021 | 43,958 | $428.0K | 0.3% | +2,483+6.0% | Added | Holders |
| Q2 2021 | 41,475 | $593.0K | 0.4% | +1,475+3.7% | Added | Holders |
| Q1 2021 | 40,000 | $974.0K | 0.7% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.